Search research articles
Contact Us
Filters
Showing results (1-10 of 99) with videos related to
Page
of 10
Sort By:
Pharmaceutics
|
January 21, 2022
Mitochondria-Targeted Drug Delivery
Joanna Kopecka
Cancers
|
July 24, 2021
Malignant Mesothelioma
Daniel L Pouliquen, Joanna Kopecka
The International Journal of Biochemistry & Cell Biology
|
November 9, 2020
Cholesterol metabolism: At the cross road between cancer cells and immune environment
Joanna Kopecka, Martina Godel, Chiara Riganti
Journal of the National Cancer Institute
|
March 14, 2015
The role of C/EBP-β LIP in multidrug resistance
Chiara Riganti, Joanna Kopecka, Elisa Panada, et al.
International Journal of Molecular Sciences
|
May 24, 2019
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
Iris C Salaroglio, Eleonora Mungo, Elena Gazzano, et al.
Antioxidants (Basel, Switzerland)
|
April 3, 2021
IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine
Cecilia Roux, Gianluca Mucciolo, Joanna Kopecka, et al.
Bioorganic Chemistry
|
June 24, 2025
Two are better than one: A case study of the biferrocenyl-thymidine "click" conjugate biFcT as novel ferroptosis-inducing agent in lung cancer cells
Angelo Meoli, Chiara Riganti, Costanzo Costamagna, et al.
International Journal of Molecular Sciences
|
December 21, 2017
ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy
Paola Antonia Corsetto, Irma Colombo, Joanna Kopecka, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
September 29, 2021
Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models
Mauro Niso, Joanna Kopecka, Francesca Serena Abatematteo, et al.
Cytokine & Growth Factor Reviews
|
May 24, 2023
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance
Bárbara Polónia, Cristina P R Xavier, Joanna Kopecka, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 99) with videos related to
Sort By:
Page
of 10
Pharmaceutics
|
January 21, 2022
Mitochondria-Targeted Drug Delivery
Joanna Kopecka
Cancers
|
July 24, 2021
Malignant Mesothelioma
Daniel L Pouliquen, Joanna Kopecka
The International Journal of Biochemistry & Cell Biology
|
November 9, 2020
Cholesterol metabolism: At the cross road between cancer cells and immune environment
Joanna Kopecka, Martina Godel, Chiara Riganti
Journal of the National Cancer Institute
|
March 14, 2015
The role of C/EBP-β LIP in multidrug resistance
Chiara Riganti, Joanna Kopecka, Elisa Panada, et al.
International Journal of Molecular Sciences
|
May 24, 2019
ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer
Iris C Salaroglio, Eleonora Mungo, Elena Gazzano, et al.
Antioxidants (Basel, Switzerland)
|
April 3, 2021
IL17A Depletion Affects the Metabolism of Macrophages Treated with Gemcitabine
Cecilia Roux, Gianluca Mucciolo, Joanna Kopecka, et al.
Bioorganic Chemistry
|
June 24, 2025
Two are better than one: A case study of the biferrocenyl-thymidine "click" conjugate biFcT as novel ferroptosis-inducing agent in lung cancer cells
Angelo Meoli, Chiara Riganti, Costanzo Costamagna, et al.
International Journal of Molecular Sciences
|
December 21, 2017
ω-3 Long Chain Polyunsaturated Fatty Acids as Sensitizing Agents and Multidrug Resistance Revertants in Cancer Therapy
Paola Antonia Corsetto, Irma Colombo, Joanna Kopecka, et al.
Cellular Oncology (Dordrecht, Netherlands)
|
September 29, 2021
Multifunctional thiosemicarbazones targeting sigma receptors: in vitro and in vivo antitumor activities in pancreatic cancer models
Mauro Niso, Joanna Kopecka, Francesca Serena Abatematteo, et al.
Cytokine & Growth Factor Reviews
|
May 24, 2023
The role of Extracellular Vesicles in glycolytic and lipid metabolic reprogramming of cancer cells: Consequences for drug resistance
Bárbara Polónia, Cristina P R Xavier, Joanna Kopecka, et al.
Page
of 10